6th Oligonucleotides for CNS Summit 2026
-
Location:
- The Colonnade Hotel
- 120 Huntington Avenue
- Boston
- Massachusetts
- 02116
- United States
- View on a map
- More Information:
-
Contact:
- Organiser: Hanson Wade Conferences Ltd
- Name: Phoebe Walsh
- Email: info@hansonwade.com
- Telephone: +16174554188
Oligonucleotide R and D is accelerating, driven by advances in brain shuttle technologies, RNA chemistry, and growing clinical validation from leaders such as Alnylam Pharmaceuticals, Stoke Therapeutics, and Ionis Pharmaceuticals. At the same time, major investments, including Novartis into Arrowhead Pharmaceuticals, Biogen into City Therapeutics, and Roche into Manifold Bio, underscore CNS as a key frontier for these technologies, unlocking previously undruggable targets.
Building on last year's momentum, the 6th Annual Oligonucleotides for CNS Summit will bring together 160+ experts across CNS biology, oligo chemistry, RNA science, and DMPK. Attendees will explore the latest innovations advancing nucleic acid therapies for neurodegenerative, neuromuscular, rare, epileptic, and neurodevelopmental disorders.
This summit uniquely connects stakeholders at the intersection of oligonucleotides and CNS. Join leaders from Eli Lilly, Dyne Therapeutics, Creyon Bio, and more for three days of collaboration to accelerate RNA-targeted CNS therapies.
Date and Time: Wednesday, 19 August 2026 at 08:00 - Friday, 21 August 2026 at 17:00
